$429 Million is the total value of Samsara BioCapital, LLC's 56 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 1.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | CHINOOK THERAPEUTICS INC | $101,483,000 | +12.4% | 5,161,888 | 0.0% | 23.66% | -1.7% | |
| NKTX | NKARTA INC | $37,743,000 | +6.8% | 2,868,035 | 0.0% | 8.80% | -6.6% | |
| SRRK | SCHOLAR ROCK HLDG CORP | $31,870,000 | +26.2% | 4,598,828 | 0.0% | 7.43% | +10.4% | |
| GRPH | GRAPHITE BIO INC | $26,816,000 | +15.3% | 8,459,314 | 0.0% | 6.25% | +0.8% | |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $21,255,000 | +97.1% | 1,065,413 | -31.9% | 4.96% | +72.4% |
| ARCELLX INC | $19,968,000 | +3.8% | 1,063,835 | 0.0% | 4.66% | -9.2% | ||
| ISEE | Sell | IVERIC BIO INC | $14,496,000 | +49.2% | 808,041 | -20.0% | 3.38% | +30.5% |
| ACRS | ACLARIS THERAPEUTICS INC | $10,958,000 | +12.7% | 696,171 | 0.0% | 2.56% | -1.4% | |
| Sell | HILLEVAX INC | $10,426,000 | +25.1% | 610,062 | -20.0% | 2.43% | +9.4% | |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $9,595,000 | +106.1% | 938,890 | -15.5% | 2.24% | +80.3% |
| STRO | SUTRO BIOPHARMA INC | $9,299,000 | +6.5% | 1,675,579 | 0.0% | 2.17% | -6.8% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $8,938,000 | +1.0% | 640,688 | 0.0% | 2.08% | -11.7% | |
| LYRA | LYRA THERAPEUTICS INC | $8,904,000 | -11.3% | 1,777,251 | 0.0% | 2.08% | -22.5% | |
| TIL | INSTIL BIO INC | $8,655,000 | +4.8% | 1,788,280 | 0.0% | 2.02% | -8.4% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $8,460,000 | +490.4% | 345,293 | 0.0% | 1.97% | +416.5% | |
| RAIN | RAIN THERAPEUTICS INC | $7,616,000 | -12.2% | 1,560,652 | 0.0% | 1.78% | -23.2% | |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $6,809,000 | -17.4% | 1,693,736 | 0.0% | 1.59% | -27.8% | |
| ZYME | ZYMEWORKS INC | $5,972,000 | +16.1% | 970,987 | 0.0% | 1.39% | +1.5% | |
| PEPGEN INC | $5,912,000 | -8.6% | 651,050 | 0.0% | 1.38% | -20.0% | ||
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $5,677,000 | +210.4% | 881,450 | -53.6% | 1.32% | +171.3% |
| DICE THERAPEUTICS INC | $5,140,000 | +30.7% | 253,466 | 0.0% | 1.20% | +14.3% | ||
| JYAC | JIYA ACQUISITION CORP | $5,055,000 | +0.9% | 507,041 | 0.0% | 1.18% | -11.7% | |
| JANX | JANUX THERAPEUTICS INC | $4,880,000 | +10.9% | 360,414 | 0.0% | 1.14% | -3.0% | |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $3,934,000 | +11.9% | 196,425 | 0.0% | 0.92% | -2.1% | |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $3,800,000 | -36.7% | 80,963 | -49.7% | 0.89% | -44.7% |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $3,797,000 | +0.5% | 480,000 | 0.0% | 0.88% | -12.1% | |
| IGMS | IGM BIOSCIENCES INC | $3,517,000 | +26.1% | 154,664 | 0.0% | 0.82% | +10.4% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,304,000 | +105.3% | 659,409 | 0.0% | 0.77% | +79.5% | |
| BLSA | BCLS ACQUISITION CORP | $3,006,000 | +1.2% | 300,000 | 0.0% | 0.70% | -11.5% | |
| VIRX | VIRACTA THERAPEUTICS INC | $2,945,000 | +10.1% | 689,709 | 0.0% | 0.69% | -3.6% | |
| DBTX | DECIBEL THERAPEUTICS INC | $2,774,000 | -17.8% | 801,629 | 0.0% | 0.65% | -28.1% | |
| IO BIOTECH INC | $2,733,000 | -42.0% | 1,008,437 | 0.0% | 0.64% | -49.2% | ||
| ALXO | ALX ONCOLOGY HLDGS INC | $2,515,000 | +18.3% | 262,786 | 0.0% | 0.59% | +3.4% | |
| TANGO THERAPEUTICS INC | $2,281,000 | -20.1% | 630,000 | 0.0% | 0.53% | -30.1% | ||
| AMYT | AMRYT PHARMA PLCsponsored ads | $2,109,000 | -1.0% | 304,715 | 0.0% | 0.49% | -13.4% | |
| ALBO | ALBIREO PHARMA INC | $1,936,000 | -2.5% | 100,000 | 0.0% | 0.45% | -14.7% | |
| TERN | TERNS PHARMACEUTICALS INC | $1,703,000 | +137.5% | 289,068 | 0.0% | 0.40% | +107.9% | |
| VTVT | VTV THERAPEUTICS INCcl a | $1,586,000 | +29.3% | 1,635,509 | 0.0% | 0.37% | +13.1% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,553,000 | -27.4% | 1,049,153 | 0.0% | 0.36% | -36.5% | |
| SCIENCE 37 HOLDINGS INC | $1,449,000 | -19.9% | 900,000 | 0.0% | 0.34% | -29.9% | ||
| EQ | EQUILLIUM INC | $1,367,000 | +8.8% | 615,541 | 0.0% | 0.32% | -4.8% | |
| ALLK | ALLAKOS INC | $1,053,000 | +95.4% | 172,089 | 0.0% | 0.25% | +70.8% | |
| ELEV | ELEVATION ONCOLOGY INC | $939,000 | -19.3% | 830,565 | 0.0% | 0.22% | -29.4% | |
| ALVR | ALLOVIR INC | $650,000 | +102.5% | 82,336 | 0.0% | 0.15% | +76.7% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $633,000 | +15.7% | 22,204 | 0.0% | 0.15% | +1.4% | |
| BCEL | ATRECA INC | $623,000 | -12.3% | 396,835 | 0.0% | 0.14% | -23.3% | |
| SURROZEN INC | $606,000 | -32.7% | 300,000 | 0.0% | 0.14% | -41.2% | ||
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $465,000 | +4.3% | 883,720 | 0.0% | 0.11% | -9.2% | |
| NVAX | NOVAVAX INCcall | $426,000 | -64.6% | 23,400 | 0.0% | 0.10% | -69.2% | |
| NVAX | NOVAVAX INC | $387,000 | -64.6% | 21,244 | 0.0% | 0.09% | -69.1% | |
| KRON | KRONOS BIO INC | $262,000 | -7.7% | 78,131 | 0.0% | 0.06% | -19.7% | |
| ASTRIA THERAPEUTICS INC | $226,000 | +201.3% | 25,000 | 0.0% | 0.05% | +165.0% | ||
| NGM | NGM BIOPHARMACEUTICALS INC | $179,000 | +2.3% | 13,669 | 0.0% | 0.04% | -10.6% | |
| KALA | KALA PHARMACEUTICALS INC | $132,000 | -26.7% | 601,162 | 0.0% | 0.03% | -35.4% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $27,000 | -27.0% | 133,333 | 0.0% | 0.01% | -40.0% | |
| SURROZEN INC*w exp 08/01/203 | $18,000 | -5.3% | 99,999 | 0.0% | 0.00% | -20.0% | ||
| RXRX | Exit | RECURSION PHARMACEUTICALS INcl a | $0 | – | -267,996 | -100.0% | -0.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.